[go: up one dir, main page]

NO20062360L - Et universelt anvendelig virus-inaktivert blodplasma fremstilt fra deler av ikke-kaukasisk plasma - Google Patents

Et universelt anvendelig virus-inaktivert blodplasma fremstilt fra deler av ikke-kaukasisk plasma

Info

Publication number
NO20062360L
NO20062360L NO20062360A NO20062360A NO20062360L NO 20062360 L NO20062360 L NO 20062360L NO 20062360 A NO20062360 A NO 20062360A NO 20062360 A NO20062360 A NO 20062360A NO 20062360 L NO20062360 L NO 20062360L
Authority
NO
Norway
Prior art keywords
blood
plasma
parts
caucasian
blood plasma
Prior art date
Application number
NO20062360A
Other languages
English (en)
Norwegian (no)
Inventor
Tor-Einar Svae
Juergen Romisch
Andrea Heger
Wolfgang Marguerre
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of NO20062360L publication Critical patent/NO20062360L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01GCOMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G23/00Compounds of titanium
    • C01G23/04Oxides; Hydroxides
    • C01G23/047Titanium dioxide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/16Blood plasma; Blood serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25Silicon; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/29Titanium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82BNANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B3/00Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Birds (AREA)
  • Immunology (AREA)
  • Nanotechnology (AREA)
  • Manufacturing & Machinery (AREA)
  • Environmental & Geological Engineering (AREA)
  • General Life Sciences & Earth Sciences (AREA)
  • Geology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • External Artificial Organs (AREA)
NO20062360A 2003-12-19 2006-05-23 Et universelt anvendelig virus-inaktivert blodplasma fremstilt fra deler av ikke-kaukasisk plasma NO20062360L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03029359 2003-12-19
PCT/EP2004/053608 WO2005058334A1 (en) 2003-12-19 2004-12-20 A universally applicable virus inactivated blood plasma produced from portions of non-caucasian plasma

Publications (1)

Publication Number Publication Date
NO20062360L true NO20062360L (no) 2006-05-23

Family

ID=34684548

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20062360A NO20062360L (no) 2003-12-19 2006-05-23 Et universelt anvendelig virus-inaktivert blodplasma fremstilt fra deler av ikke-kaukasisk plasma

Country Status (23)

Country Link
US (2) US20070071829A1 (pl)
EP (1) EP1696940B1 (pl)
JP (1) JP2007514716A (pl)
KR (1) KR101077976B1 (pl)
CN (1) CN1893960B (pl)
AT (1) ATE357242T1 (pl)
AU (1) AU2004298790B2 (pl)
BR (1) BRPI0417680A (pl)
CA (1) CA2550060A1 (pl)
CY (1) CY1106661T1 (pl)
DE (1) DE602004005501T2 (pl)
DK (1) DK1696940T3 (pl)
ES (1) ES2281848T3 (pl)
IL (1) IL175558A0 (pl)
NO (1) NO20062360L (pl)
PL (1) PL1696940T3 (pl)
PT (1) PT1696940E (pl)
RS (1) RS50508B (pl)
RU (1) RU2362571C2 (pl)
SI (1) SI1696940T1 (pl)
UA (1) UA83528C2 (pl)
WO (1) WO2005058334A1 (pl)
ZA (1) ZA200604941B (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1958618A1 (de) 2007-02-15 2008-08-20 Octapharma AG Verfahren zur Gefriertrocknung mit optimierter Rekonstitution von Biopolymeren
FR2963737B1 (fr) * 2010-08-16 2013-04-05 Etat Francais Ministere De La Defense Service De Sante Des Armees Procede de lyophilisation de plasma sanguin
EP3093035A1 (en) 2015-05-13 2016-11-16 Sanofi-Aventis Deutschland GmbH Injection device for delivery of a liquid medicament
CN107496453A (zh) * 2017-08-13 2017-12-22 发贵科技(贵州)有限公司 一种有病毒灭活功能的血浆抗凝剂

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4664913A (en) * 1982-05-24 1987-05-12 Xoma Corporation Method for treating plasma for transfusion
US4764369A (en) * 1983-07-14 1988-08-16 New York Blood Center Inc. Undenatured virus-free biologically active protein derivatives
US5217627A (en) * 1990-11-06 1993-06-08 Pall Corporation System and method for processing biological fluid
AU667530B2 (en) * 1992-05-28 1996-03-28 New York Blood Center, Inc., The Removal of antibodies from blood-derived compositions while retaining coagulation factors
DE19729778A1 (de) * 1997-07-11 1999-01-21 Blutspendedienst Der Drk Lande Verfahren zur Herstellung von virusinaktivierten biologischen Flüssigkeiten
EP0896824A1 (en) * 1997-08-05 1999-02-17 Octapharma Ag A universally applicable blood plasma
CN1207004C (zh) * 2001-04-18 2005-06-22 马建川 通用型冻干血浆及其制备方法
US20030133829A1 (en) * 2001-12-21 2003-07-17 Baxter Healthcare Corporation Process for inactivating pathogens in a biological material

Also Published As

Publication number Publication date
SI1696940T1 (sl) 2007-08-31
PT1696940E (pt) 2007-05-31
WO2005058334A1 (en) 2005-06-30
DK1696940T3 (da) 2007-07-30
BRPI0417680A (pt) 2007-03-20
CN1893960B (zh) 2012-10-31
DE602004005501D1 (de) 2007-05-03
CN1893960A (zh) 2007-01-10
RU2362571C2 (ru) 2009-07-27
ES2281848T3 (es) 2007-10-01
KR20060126662A (ko) 2006-12-08
RU2006126055A (ru) 2008-01-27
EP1696940A1 (en) 2006-09-06
RS50508B (sr) 2010-03-02
US20110104298A1 (en) 2011-05-05
US20070071829A1 (en) 2007-03-29
KR101077976B1 (ko) 2011-10-28
DE602004005501T2 (de) 2007-11-29
EP1696940B1 (en) 2007-03-21
CY1106661T1 (el) 2012-05-23
IL175558A0 (en) 2006-09-05
AU2004298790A1 (en) 2005-06-30
AU2004298790B2 (en) 2010-04-08
JP2007514716A (ja) 2007-06-07
CA2550060A1 (en) 2005-06-30
UA83528C2 (uk) 2008-07-25
ATE357242T1 (de) 2007-04-15
ZA200604941B (en) 2007-11-28
PL1696940T3 (pl) 2007-08-31

Similar Documents

Publication Publication Date Title
Santos-Medellín et al. Prolonged drought imparts lasting compositional changes to the rice root microbiome
Yang et al. Evolutionary dynamics of bacteria in a human host environment
Futschik et al. Noise-robust soft clustering of gene expression time-course data
Becker et al. The effect of captivity on the cutaneous bacterial community of the critically endangered Panamanian golden frog (Atelopus zeteki)
NO20064388L (no) Kaseinavledede peptider og terapeutiske anvendelser derav
Tissot et al. New genotyping method discovers sustained nosocomial Pseudomonas aeruginosa outbreak in an intensive care burn unit
NO20076059L (no) 2,4-Diamino-pyrimidiner anvendt som aurorainhibitorer
NO20081087L (no) Fremgangsmater for fremstilling av sterilisert pankreatinpulver
EA201270574A1 (ru) Способы и системы для фармакогеномного лечения сердечно-сосудистых заболеваний
Piwosz et al. Light and primary production shape bacterial activity and community composition of aerobic anoxygenic phototrophic bacteria in a microcosm experiment
Bryner et al. Hypovirus virulence and vegetative incompatibility in populations of the chestnut blight fungus
SG178797A1 (en) Oligosaccharide chain added glp-1 peptide
NO20076391L (no) Sammensetninger og metoder for behandling av tilstander relatert til efrinsignaler med cupredoxin
Albanese et al. Genome sequencing provides new insights on the distribution of Erwinia amylovora lineages in northern Italy
DE502006008908D1 (de) Verwendung von genaktivitäts-klassifikatoren für die in vitro klassifizierung von genexpressionsprofilen von patienten mit infektiösem/nichtinfektiösem multiorganversagen
NO20062360L (no) Et universelt anvendelig virus-inaktivert blodplasma fremstilt fra deler av ikke-kaukasisk plasma
Snyder et al. The phylogeny of Sodalis-like symbionts as reconstructed using surface-encoding loci
NO20076389L (no) Sammenstninger og metoder for behandling av HIV-infeksjon med cupredoxin og cytokrom C
NO20055227L (no) Stamceller med okt sensitivitet for en kjemoattraktant og fremgangsmater for fremstilling og anvendelse derav
Peña-Ponton et al. High-resolution methylome analysis in the clonal Populus nigra cv.‘Italica’reveals environmentally sensitive hotspots and drought-responsive TE superfamilies
Velázquez et al. Association of citrus psorosis B symptoms with a sequence variant of the Citrus psorosis virus RNA 2
Tambarussi et al. Microsatellite markers for Cariniana legalis (Lecythidaceae) and their transferability to C. estrellensis
Baggio et al. Differentiation within and between river basins of Podostemum irgangii (Podostemaceae), a rapid-water macrophyte of southern Brazil
ATE334209T1 (de) Inaktivierung von genen des mep-wegs
Seaton et al. Curtobacterium glycinis sp. nov. from Glycine max, Curtobacterium gossypii sp. nov. from Gossypium hirsutum and Curtobacterium oryzae sp. nov. from Oryza sativa, three new Curtobacterium species and endophytes from agricultural crops

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application